RT Book, Section
A1 Havrda, Dawn
A2 Linn, William D.
SR Print(0)
ID 1191746614
T1 The impact of finerenone in stage 3 and 4 diabetic kidney disease—the FIDELIO-DKD trial.
T2 Topics in Evidence-Based Pharmacy Practice
YR 2016
FD 2016
PB McGraw Hill
PP New York, NY
SN 
LK accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=594028
RD 2024/04/19
AB